175 related articles for article (PubMed ID: 35158993)
1. Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes.
Forrester JD; Foster D; Ford JM; Longacre TA; Ladabaum U; Fry S; Norton JA
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158993
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
4. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
5. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
[TBL] [Abstract][Full Text] [Related]
7. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
8. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
9. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.
Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F
Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
11. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin mutations and hereditary gastric cancer: prevention by resection?
Fitzgerald RC; Caldas C
Dig Dis; 2002; 20(1):23-31. PubMed ID: 12145417
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
15. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
Shenoy S
Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
[TBL] [Abstract][Full Text] [Related]
16. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
Luo W; Fedda F; Lynch P; Tan D
Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
[TBL] [Abstract][Full Text] [Related]
17. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
18. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.
Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Ahsan F; Oliveri F; Rutkofsky IH
Cureus; 2020 Sep; 12(9):e10406. PubMed ID: 33062523
[TBL] [Abstract][Full Text] [Related]
19. Hereditary diffuse gastric cancer in a Japanese family with CDH1 mutation three case reports.
Muranaka F; Kise E; Tokumaru S; Kitazawa M; Miyagawa Y; Suga T; Uehara T; Iwaya M; Kobayashi S; Sato M; Gomi D; Yamada H; Sugimura H; Kosho T; Soejima Y; Koizumi T
Discov Oncol; 2023 Jan; 14(1):14. PubMed ID: 36719602
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]